CRP and bacterial infectious disease: C-reactive protein (CRP) as a biomarker of bacterial infection is one of these interventions (Lubell et al., 2015), and new point-of-care testing (POCT) solutions are hoped to become an additional tool for low- and middle-income countries (LMICs) to limit the growing problem of AMR (Do et al., 2016; Drain et al., 2014; Lubell and Althaus, 2017).